In our study, the levels of AMH one month after ChT (AMH1) were extremely low, the AMH and AFC decreased significantly two years after BC treatment (P < 0.001 for both), and a high rate of amenorrhea (45.24%) was observed without any relation to the menstrual pattern at entry. The gene discussed is AMH; the disease is amenorrhea.